QR Code

A Descriptive, Post Hoc Analysis of Efficacy and Safety of Risankizumab in Diverse Racial and Ethnic Patient Populations With Moderate-to-Severe Psoriasis

Abstract Introduction Historically, patients with skin of color are underdiagnosed with psoriasis and underrepresented in clinical trials. In this study, we assess the efficacy and safety of risankizumab in patients with moderate-to-severe plaque psoriasis by race and ethnicity in the open label ext...

Full description

Saved in:
Main Authors: Andrew F. Alexis, Melinda Gooderham, Shawn G. Kwatra, Ahmad Amin, Susan Taylor, Ramon Espaillat, Trisha Rettig, Tianshuang Wu, Linyu Shi, Mark I. Kaldas, Deanne M. Dilley, Ranjeeta Sinvhal, Chudy Nduaka, Benjamin Lockshin
Format: Artigo
Language:Inglês
Published: Adis, Springer Healthcare 2024-10-01
Series:Dermatology and Therapy
Subjects:
Skin of color
Psoriasis
Race
Ethnicity
Efficacy
Diversity
Online Access:https://doi.org/10.1007/s13555-024-01268-z
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items